Rising Pharmaceuticals recalls

3 official recalls and safety alerts involving Rising Pharmaceuticals since 2021-10, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Rising Pharmaceuticals or the relevant agency.

1. 2023-03-01
2. US
   Drugs & medicalClass II

   RISING PHARMACEUTICALS recalls Warfarin Sodium Tablets, USP 1 mg, 100-count bottle, Rx Only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC# 57237-119-01

   Failed Impurities/Degradation Specifications

   FDA · DrugRISING PHARMACEUTICALSProduct was distributed to 16 distributors and 8 wholesalers who may have…Official notice →
3. 2022-03-02
4. US
   Drugs & medicalClass II

   RISING PHARMACEUTICALS recalls Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle…

   Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared…

   FDA · DrugRISING PHARMACEUTICALSNationwide in the USAOfficial notice →
5. 2021-10-13
6. US
   Drugs & medicalClass II

   RISING PHARMACEUTICALS recalls Meclizine HCl Tablets, 25 mg, packaged in 100-count HDPE bottle, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816,…

   Labeling: Incorrect Instructions

   FDA · DrugRISING PHARMACEUTICALSto be enteredOfficial notice →